Helicobacter pylori was first observed in 1983 infecting human stomachs and causing gastritis. It is a unique, fastidious bacterium that colonizes the gastric mucosa and is highly adapted to survive the acidic stomach environment. H. pylori infection is strongly associated with peptic ulcer disease, gastric cancer, and gastric MALT lymphoma. Successful treatment requires combination antibiotic therapy alongside proton pump inhibitors or bismuth compounds to eradicate the infection.
8. History of HelicobacterHistory of Helicobacter
ï First observed in 1983 asFirst observed in 1983 as CampylobacterCampylobacter-like-like
organisms (CLO) in stomachs with gastritisorganisms (CLO) in stomachs with gastritis
ï HelicobacterHelicobacter was coined in 1989.was coined in 1989. 20 spp. Are known.20 spp. Are known.
Only 3 cause human d.Only 3 cause human d.
1. Hp1. Hp (human;(human; no animal reservoir)no animal reservoir)
2. H. cinaedi2. H. cinaedi (male homosexuals; rodents)(male homosexuals; rodents)
3. H. fenneliae3. H. fenneliae (do)(do)
9. ï¶ 1983:1983: discovered by Warren and Marshall (Australia)discovered by Warren and Marshall (Australia)
ï¶ ItIt revolutionisedrevolutionised Rx of DU and GURx of DU and GU
ï¶ Earned themEarned them NobelNobel in 2005in 2005
ï¶ HpHp colonises stomach. Molecular studies: transmissioncolonises stomach. Molecular studies: transmission
occurred from animaloccurred from animal
ï¶ Monkey, cat, dog, cheetahMonkey, cat, dog, cheetah all harbour their own speciesall harbour their own species
History of Hp âŠHistory of Hp âŠ
10. HpHp DescriptionDescription
G-ve, motile, flagellate, helical; pleomorphic rod:G-ve, motile, flagellate, helical; pleomorphic rod:
penetrates and colonizespenetrates and colonizes gastricgastric mucosa (corkscrew)mucosa (corkscrew)
ï¶Fastidious in growth: strictly micro-aerophilic; require
C02. Becomes coccoid in O2 or upon prolonged cultureBecomes coccoid in O2 or upon prolonged culture
ï¶Highly adaptiveHighly adaptive
ï¶Has a tuft of unipolar flagellae; specially adapted to
colonise mucosa
ï¶Very fragile (important! when referring samples to lab)
11. HpHp is unique!is unique!
ï¶ 50%50% world popn. are inf.world popn. are inf.
ï¶ Survives acidity even at pH <2Survives acidity even at pH <2
ï¶ Colonization is chr. and may be lifelongColonization is chr. and may be lifelong
ï¶ Motility is essential for colonisationMotility is essential for colonisation
ï¶ Hallmark isHallmark is urease:urease: urea to C02 + NH3(a strong base;urea to C02 + NH3(a strong base;
neutralizes strong acid). It isneutralizes strong acid). It is essential for survivalessential for survival
ï¶ It is a carcinogenIt is a carcinogen
ï¶ Vacuolating cytotoxin (VacA): increases bacterial fitnessVacuolating cytotoxin (VacA): increases bacterial fitness
ï¶ StaysStays remote and protected from immune sys.remote and protected from immune sys.
12. EpidemiologyEpidemiology
ï¶ Worldwide. Varies greatly among countries and popn.Worldwide. Varies greatly among countries and popn.
ï¶ 20 â 50% among mid-age adults in20 â 50% among mid-age adults in HICsHICs
ï¶ >80%>80% inin L&MICs;L&MICs; 85% by 2yoa85% by 2yoa
Transmission:Transmission: ingestion; commonest: family contact (esp.ingestion; commonest: family contact (esp.
children).children). HpHp has been cultured from feces, dentalhas been cultured from feces, dental
caries.caries. Transmission increases with ageTransmission increases with age
Site of inf.:Site of inf.: gastric antrum (most favoured), bodygastric antrum (most favoured), body
ï¶ Present in the mucus secretionPresent in the mucus secretion
13.
14. PATHOPHYSIOLOGYPATHOPHYSIOLOGY
HpHp is the first recognized bacterialis the first recognized bacterial carcinogencarcinogen and is 1 ofand is 1 of
most successful pathogens. Colonization is usually lifelongmost successful pathogens. Colonization is usually lifelong
It causesIt causes chr. gastritischr. gastritis (may be asymptomatic),(may be asymptomatic), PUD, gastricPUD, gastric
Ca, gastric MALT lymphoma, gastric atrophyCa, gastric MALT lymphoma, gastric atrophy
Outcome depends on interplay between host &Outcome depends on interplay between host & Hp.Hp. HostHost
immunity and gastric a. largely determine colonizationimmunity and gastric a. largely determine colonization
HpHp makesmakes ammoniaammonia (toxic to epith),(toxic to epith), proteasesproteases,, vacuolatingvacuolating
cytotoxin A (VacA)cytotoxin A (VacA) [damages epith, disrupts tight junctions[damages epith, disrupts tight junctions
and causes apoptosis),and causes apoptosis), phospholipases.phospholipases. CytotoxinCytotoxin
associated geneassociated gene CagACagA can causes inflam. and is carcinogencan causes inflam. and is carcinogen
15. PUD:PUD: acid & pepsin overcome mucosal defenceacid & pepsin overcome mucosal defence
Site of colonizationSite of colonization affects location of ulceraffects location of ulcer
ï In large amounts of acid,In large amounts of acid, HpHp colonizes the antrum; avoidcolonizes the antrum; avoid
fundal parietal cellsfundal parietal cells
ï In normal or reduced acid,In normal or reduced acid, HpHp colonizes rest of stomachcolonizes rest of stomach
Inflam. in antrum inducesInflam. in antrum induces G cellsG cells to secrete gastrin: moreto secrete gastrin: more
acid, also increases parietal cell number. Increased acidacid, also increases parietal cell number. Increased acid
load damages duodenum (DU)load damages duodenum (DU)
When Hp colonizes other areas of stomach, inflam. can result When Hp colonizes other areas of stomach, inflam. can resultÂ
in atrophy of the stomach lining and eventually ulcers; Cain atrophy of the stomach lining and eventually ulcers; Ca
16. HpHp infinf directlydirectly associateassociatedd withwith
ï¶ PUDPUD
- lifetime risk 3% in US, 25% Japan- lifetime risk 3% in US, 25% Japan
- eradication provides long-term cure- eradication provides long-term cure
ï¶ Gastric CaGastric Ca
- strong evidence of risk 0.1-3%- strong evidence of risk 0.1-3%
-- unclearunclear if eradication reduces the riskif eradication reduces the risk
ï¶ MALT lymphomaMALT lymphoma
-- 72%â 98% of MALT lymphoma infected with72%â 98% of MALT lymphoma infected with HpHp
Mucosa-associated lymphoid tissue: MALT
20. ChildhoodChildhood HpHp gastric Ca isgastric Ca is not reportednot reported. Gastric atrophy and. Gastric atrophy and
intestinal metaplasia are risk factors for Caintestinal metaplasia are risk factors for Ca
HpHp inf typically causes (CMI) gastritis: hypergastrinaemia andinf typically causes (CMI) gastritis: hypergastrinaemia and
hyperacidity. Infected stomach can have normal secretionhyperacidity. Infected stomach can have normal secretion
Antral predominant d.Antral predominant d. commonly has hypergastrinaemia,commonly has hypergastrinaemia,
DU, gastric metaplasia of duodenum.DU, gastric metaplasia of duodenum.Antral predominant d.Antral predominant d.
is probably higher in childrenis probably higher in children
But gastric Ca is more common in body predominant d.:But gastric Ca is more common in body predominant d.:
hypochorhydria and atrophy of parietal cells. Whenhypochorhydria and atrophy of parietal cells. When Hp Hp willwill
cause an antral/body predominant d. is unclearcause an antral/body predominant d. is unclear
Host response âŠHost response âŠ
21. EM:EM: HpHp on the gastricon the gastric
mucosa of a childmucosa of a child
22. Section of a gastric biopsy:Section of a gastric biopsy: HpHp gastritisgastritis
24. McColl K. N Engl J Med 2010;362:1597-1604
Gastric-biopsy:Gastric-biopsy: HpHp adhering to epithelium and underlying inflammationadhering to epithelium and underlying inflammation
25. DISEASE IN CHILDRENDISEASE IN CHILDREN
ï¶ Ac. & chr. GastritisAc. & chr. Gastritis
ï¶ PUD:PUD: typically DU. Classic CF are not reliable in youngtypically DU. Classic CF are not reliable in young
children; only Dx by endoscopychildren; only Dx by endoscopy
ï¶ AP without PUDAP without PUD (adult: non-ulcer dyspepsia)(adult: non-ulcer dyspepsia)
HpHp eradication doesnât help (9%). Resolution of nodulareradication doesnât help (9%). Resolution of nodular
lymphoid hyperplasia may take 6mo to resolve andlymphoid hyperplasia may take 6mo to resolve and
inflam. infiltrate 4y. It isnât sure ifinflam. infiltrate 4y. It isnât sure if HpHp has a major rolehas a major role
ï¶ GERD:GERD: there may actually be an rise in reflux inthere may actually be an rise in reflux in Hp Hp eradication Rx.eradication Rx.
SS of above d. can be v. similar. Upper GI endoscopy is the only reliableSS of above d. can be v. similar. Upper GI endoscopy is the only reliable
method of Dx, and hencemethod of Dx, and hence Hp RxHp Rx. In UK 5% of 5â16y are colonized. In UK 5% of 5â16y are colonized
withwith Hp. Hp. Most have no SSMost have no SS
26. Recurrent APRecurrent AP
Chr. gastritis without PU could be a c/of RAP in children, andChr. gastritis without PU could be a c/of RAP in children, and
screening is often done; but no consistent evidence. Mostscreening is often done; but no consistent evidence. Most
likely it is a co-existence of 2 common but unrelated d. Hplikely it is a co-existence of 2 common but unrelated d. Hp
eradication doesnât helperadication doesnât help
IDAIDA
HpHp can be a/with IDA in asymptomatic children at puberty.can be a/with IDA in asymptomatic children at puberty.
Whether this is c/by iron loss or less absorption is unclear.Whether this is c/by iron loss or less absorption is unclear.
IfIf HpHp is identified in a case of IDA, it should be eradicatedis identified in a case of IDA, it should be eradicated
Growth falteringGrowth faltering
HpHp inf. may lead to it. Confounding variables may contributeinf. may lead to it. Confounding variables may contribute
to both Mn & earlyto both Mn & early Hp Hp colonization. Ifcolonization. If HpHp were found to bewere found to be
a significant c/of it then global impact would be enormous.a significant c/of it then global impact would be enormous.
27. DIAGNOSTIC TESTSDIAGNOSTIC TESTS
Indications:Indications: SS of PUD (RAP, wt loss, NV, anemia)SS of PUD (RAP, wt loss, NV, anemia),,
indigestion, fullness/bloating, belchingindigestion, fullness/bloating, belching
1.1.UBT:UBT: sensitivity/sp. 90%. Psensitivity/sp. 90%. Presence ofresence of HpHp. C UBT are non-. C UBT are non-
radioactive; widely available.radioactive; widely available. False-ve:False-ve: active/recentactive/recent
bleeding, AB/antisecretory Rxbleeding, AB/antisecretory Rx
2.2.Serology:Serology: 82.4% sensitive and 85% sp. It82.4% sensitive and 85% sp. It is widelyis widely
available. High conc. in blood/ saliva are found in activeavailable. High conc. in blood/ saliva are found in active
inf; after Rx, these gradually fall; so, not suitable forinf; after Rx, these gradually fall; so, not suitable for
establishing short/medium term successestablishing short/medium term success
3.3. Fecal Ag tests.Fecal Ag tests. 89-98% sensitivity & >90% sp. G89-98% sensitivity & >90% sp. Goodood
guide to successful eradication. It is simple; should beguide to successful eradication. It is simple; should be
test of choice for assessing eradicationtest of choice for assessing eradication
28. 4. Endoscopy & biopsy are indicated:4. Endoscopy & biopsy are indicated:
remains theremains the gold standardgold standard for Dx. Antral biopsiesfor Dx. Antral biopsies
have the highest yield (unless pt is on PPI)have the highest yield (unless pt is on PPI)
âą Indications:Indications: Severe SS, anemia, wt loss, age >50ySevere SS, anemia, wt loss, age >50y
âą RUT:RUT: rapid detection (S 79â100%, sp. 92â100%). It hasrapid detection (S 79â100%, sp. 92â100%). It has aa
poor positive predictive value in childhood and need to bepoor positive predictive value in childhood and need to be
confirmed by histologyconfirmed by histology
âą Histology:Histology: if urease test negative (>90% sens.if urease test negative (>90% sens.
&sp.)&sp.)
5. Stool immunoassay & PCR5. Stool immunoassay & PCR (under(under
investigation)investigation)
29.
30.
31. WHO SHOULD BE TESTED?WHO SHOULD BE TESTED?
Test in all situations that may influence Mx: test only if youTest in all situations that may influence Mx: test only if you
want to treat.want to treat. For adults:For adults: all cases ofall cases of HpHp should be treated,should be treated,
regardless of lesionregardless of lesion
Strategy of Rx dyspepsia without rapid wt loss, GI bleed, orStrategy of Rx dyspepsia without rapid wt loss, GI bleed, or
anemia: PPI x1moanemia: PPI x1mo
Do endoscopy only in persistent SS. There is a low thresholdDo endoscopy only in persistent SS. There is a low threshold
in testingin testing HpHp colonisation in adults, and even though non-colonisation in adults, and even though non-
ulcer dyspepsia is unlikely to resolve swiftly afterulcer dyspepsia is unlikely to resolve swiftly after
eradication, the balance of risk to the individual pt iseradication, the balance of risk to the individual pt is
thought to favor empirical Rxthought to favor empirical Rx
32.
33.
34. First line therapyFirst line therapy
PPI b.d. + clarithromycin 500mg b.d.PPI b.d. + clarithromycin 500mg b.d.
++
amoxicillin 1000mg b.d/metro- 400mg BD minimum of 7damoxicillin 1000mg b.d/metro- 400mg BD minimum of 7d
In case of failureIn case of failure
Second line therapySecond line therapy
PPI b.d. + bismuth subsalicylate/subcitrate 120mg QDS + metro- 500mgPPI b.d. + bismuth subsalicylate/subcitrate 120mg QDS + metro- 500mg
t.d.s. + tetracycline 500mg q.d.s. min. 7dt.d.s. + tetracycline 500mg q.d.s. min. 7d
If bismuth is NA, PPI based triple therapies should be usedIf bismuth is NA, PPI based triple therapies should be used
Subsequent failures should be handled on a case-case basis. PatientsSubsequent failures should be handled on a case-case basis. Patients
failing second-line therapy in primary care should be referredfailing second-line therapy in primary care should be referred
TreatmentTreatment
35. TREATMENTTREATMENT
Principles are similar to any inf, but more bactericidal effect isPrinciples are similar to any inf, but more bactericidal effect is
essential. Even v. small residual Hp will re-coloniseessential. Even v. small residual Hp will re-colonise
ï¶ Re-colonization means risk ofRe-colonization means risk of ABR.ABR. So, ensure complianceSo, ensure compliance
ï¶ Treat only those who will benefit. Check eradication with aTreat only those who will benefit. Check eradication with a
UBT/fecal Ag 8w later. If failed, consider 2nd line.UBT/fecal Ag 8w later. If failed, consider 2nd line.
Repeated failures need repeat endoscopy & CSRepeated failures need repeat endoscopy & CS
ï¶ Non-invasive testing of family, & Rx may be usefulNon-invasive testing of family, & Rx may be useful
ï¶ PUDPUD further requires antacid and a 3mo PPIfurther requires antacid and a 3mo PPI
ï¶ Lymphomata require oncological consult, but are veryLymphomata require oncological consult, but are very
uncommon in childrenuncommon in children
36. RecommendationsRecommendations
âą Noninvasive test-&-treat strategy forNoninvasive test-&-treat strategy for HpHp is reasonable foris reasonable for
children with upper GI SS but not alarm symptomschildren with upper GI SS but not alarm symptoms
âą Ig test is the least accurateIg test is the least accurate
âą Recurrence/persistence of SS after eradication Rx forRecurrence/persistence of SS after eradication Rx for
uninvestigated dyspepsia is much less likely to be Rxuninvestigated dyspepsia is much less likely to be Rx
failure; rather SS are unrelated tofailure; rather SS are unrelated to HpHp
âą In areas where Hp and its complications are common, Drs. testIn areas where Hp and its complications are common, Drs. test
healthy people for it. Whether there is a benefit to treatinghealthy people for it. Whether there is a benefit to treating
Hp when you have no SS is controversialHp when you have no SS is controversial
37. Key pointsKey points
>> HpHp is a flagellated spiral micro-aerobeis a flagellated spiral micro-aerobe
>> Inf. is a risk factor for gastric CaInf. is a risk factor for gastric Ca
>> Causes PUD and gastritisCauses PUD and gastritis
>> Produces a cell-damaging toxinProduces a cell-damaging toxin
>> Transmission route is unclearTransmission route is unclear
>> Rates are falling in HICsRates are falling in HICs
>> Rx is by eradication using combination therapyRx is by eradication using combination therapy
38. Common Questions/FAQCommon Questions/FAQ
Does everyone withDoes everyone with HpHp get PU?get PU?
No, many have inf. but no PU. The reason is not yet clearNo, many have inf. but no PU. The reason is not yet clear
Should everyone be tested forShould everyone be tested for HpHp??
No, only recommended for those who have SSNo, only recommended for those who have SS
How did I get infected withHow did I get infected with HpHp??
Foodborne, contaminated with human feces, vomit, saliva.Foodborne, contaminated with human feces, vomit, saliva.
Exposure from family members seems to be commonestExposure from family members seems to be commonest
Does everyone treated forDoes everyone treated for HpHp get better?get better?
The majority get rid of it. ABR may occurThe majority get rid of it. ABR may occur
39. Can I get anotherCan I get another H. pyloriH. pylori infection?infection?
Rx does not make a person immune, so there is always theRx does not make a person immune, so there is always the
potential for becoming infected againpotential for becoming infected again
Why is Ig test forWhy is Ig test for HpHp not recommended?not recommended?
We do not recommend it for routine use for Dx or Rx, as itWe do not recommend it for routine use for Dx or Rx, as it
cannot DD between a present and past inf. But, many stillcannot DD between a present and past inf. But, many still
use ituse it
If it is negative, then it is unlikely ofIf it is negative, then it is unlikely of HpHp. But if it is positive,. But if it is positive,
then a currentthen a current Hp Hp inf. should be confirmed with a stoolinf. should be confirmed with a stool
Ag/UBT/endoscopyAg/UBT/endoscopy
40. PreventionPrevention
ï¶ No vaccineNo vaccine
ï¶ Improved sanitation decreased HP; will ultimatelyImproved sanitation decreased HP; will ultimately
eliminate it in US. But, without intervention it mayeliminate it in US. But, without intervention it may
remain endemic for another centuryremain endemic for another century
ï¶ Spontaneous elimination in children is probably aided bySpontaneous elimination in children is probably aided by
ABT for other reasonsABT for other reasons
43. MCQMCQ
ï¶ Hp is a carcinogenHp is a carcinogen
ï¶ It can grow anywhere in GITIt can grow anywhere in GIT
ï¶ Monotherapy is recommendedMonotherapy is recommended
ï¶ It can cause atrophic gastritisIt can cause atrophic gastritis
ï¶ Best test is SerologicalBest test is Serological
ï¶ It causes more DU than GUIt causes more DU than GU
Editor's Notes
Later reclassified as HP
Fastidious: (Microbiology) having complex nutritional requirements
Hp can grow on different solid media containing blood/blood products. Most studies have used Brucella agar or Columbia agar as the agar base. An amount of 7-10% blood improves growth
VacA induces multiple effects on epith and lymphatic cells: vacuolation with alterations of endo-lysosomal function, anion-selective channel formation, mitochondrial damage, and inhibition CD4+ cell proliferation. VacA binds to two types of receptor-like protein tyrosine phosphatases (RPTP), RPTPα and RPTPÎČ, on the surface of target cell
GASTRIC ANTRUM
Niche. A recess in a wall, as for holding a statue or urn. A cranny, hollow, or crevice, as in rock
Apoptosis: A form of cell death in which a programmed sequence of events leads to the elimination of cells without releasing harmful substances into the surrounding area. Apoptosis plays a crucial role in developing and maintaining the health by eliminating old cells, unnecessary cells, and unhealthy cells. The human body replaces perhaps one million cells/sec. Too little or too much apoptosis can play a role in many d. When apoptosis does not work correctly, cells that should be eliminated may persist and become immortal, Eg, in Ca. When apoptosis works overly well, it kills too many cells and inflicts grave damage. This is the case in strokes and neurodegenerative d like Alzheimer&apos;s, Huntington&apos;s, and Parkinsonâs. Aka programmed cell death and cell suicide
Eradication of Hp dramatically reduces rec. of HP associated PUD. Strong evidence links it to gastric Ca. It is classed as a type I (definite carcinogen). 2.9% of HP inf. dev gastric Ca. No Ca was detected in pts who received eradication early. Eradication prevents recurrence of endoscopically resected early gastric Ca. 72 â 98% MALT lymphoma are inf with H. pylori. However, endpoint may miss the other benefits of H. pylori eradication.
GORD: Hp has been shown to have a protective role against GORD. However. Long term use of PPIs may aggravate HP mediated corpus gastritis increasing the risk of Ca.
Porins. are beta barrel proteins that cross a cellular membrane and act as a pore, through which molecules can diffuse. Unlike other membrane transport proteins, porins are large enough to allow passive diffusion (channels) that are specific to different types of molecules. They are present in outer membrane of G-ve bacteria and some G+ve of group Mycolata (mycolic acid-containing actinomycetes), the mitochondria, and the chloroplast. [poros, passageway].
Th2 cells stimulate B cells in response to extracellular pathogens. As H. pylori is non-invasive and induces a strong humoral response a Th2 response would be expected.
Studies in gene targetted mice have shown that Th2 cytokines are protective against gastric inflammation.
T-cell receptor (TCR) 1 of 2 polypeptide chains (a or Ă) on surface of T lymphocytes that recognize and
bind foreign Ag. TCRs are Ag specific; their activity depends on Ag processing by macrophages or other Ag-presenting cells and presence of MHC proteins to which peptides from the Ag are bound
Hp usually is acquired in childhood. Ac. inf causes transient hypochlorhydria and is rarely Dx. Chr. gastritis will dev. in virtually all persistently colonised cases, but 80 â 90% will never have SS. Pts with high acid output are likely to have antal predominant gastritis, predisposing them to DU. Pts with lower acid output are more likely to have corpus gastritis, prediposing GU and Ca.
T helper cells (Th cells) assist other wbc in immunologic processes: maturation of B cells into plasma cells and memory B cells, and activation of cytotoxic T cells and macrophages. Aka CD4+ T cells because they express the CD4 glycoprotein on their surfaces. Th cells become activated when they are presented with peptide Ag by MHCII molecules, which are expressed on the surface of Ag-presenting cells (APCs). Once activated, they divide rapidly and secrete small proteins called cytokines that regulate or assist in the active immune response. These cells can differentiate into one of several subtypes: TH1, 2, 3, 17, 9, or TFH, which secrete different cytokines to facilitate different types of immune responses. Signalling from the APC directs T cells into particular subtypes
Major histocompatibility complex (MHC) is a set of cell surface proteins essential for acquired immune sys to recognize foreign Ag. Its main function is to bind to Ag and display them on the cell surface for recognition by T-cells. MHC molecules mediate interactions of WBCs (immune cells), with other leukocytes or with body cells. MHC determines compatibility of donors for organ transplant, as well as one&apos;s risk to an AID via crossreacting. MHC is aka human leukocyte Ag (HLA). In a cell, protein molecules of the host&apos;s own
phenotype or of other biologic entities are continually synthesized and degraded. Each MHC molecule on the cell surface displays a molecular fraction of a protein, called an epitope. The presented Ag can be either self or non-self, thus preventing an organism&apos;s immune sys targeting its own cells. In its entirety, the MHC population is like a meter indicating the balance of proteins within the cell. The MHC gene family is divided into 3 subgroups: class I, II, III. Class I MHC molecules have ÎČ2 subunits so can only be recognized by CD8 co-receptors. Class II MHC molecules have no ÎČ2 subunits so can be recognized by CD4. In this way MHC molecules chaperone which type of lymphocytes may bind to the given Ag with high affinity, since different lymphocytes express different TCR co-receptors.
Diversity of Ag presentation, mediated by MHC classes I and II, is attained in at least 3 ways: (1) an organism&apos;s MHC repertoire is polygenic (via multiple, interacting genes); (2) MHC expression is codominant (from both sets of inherited alleles); (3) MHC gene variants are highly polymorphic (diversely varying from organism to organism within a species). MHC and sexual selection has been observed in male mice making mate choices of females with different MHCs and thus demonstrating sexual selection. Also, at least for MHC I presentation, there has been evidence of antigenic peptide splicing which can combine peptides from different proteins, vastly increasing Ag diversity
Nodular lymphoid hyperplasia (NLH) of GIT is presence of multiple small nodules, 2-10mm
In UK 20% of all GP workload are on long term acid suppression attributable to Hp
Aka: Hp; H-pylori; H. pylori Ab test; H. pylori stool Ag test; H. pylori breath test; Urea breath test; CLO test; Rapid urease test (RUT) for H. pylori
Test Preparation: You may need to avoid certain medications; follow any given instructions
Stool Ag test and UBT are recommended & are most frequently done as they are fast and noninvasive. Endoscopy-related tests may also be done
Rapid urease test, aka CLO test (Campylobacter-like organism), is a rapid Dx test for Hp. Urease converts urea to ammonia and CO2. It is done at  gastroscopy. An antral biopsy is placed into a medium containing urea and  phenol red. The urease hydrolyzes urea to ammonia, raises the pH, changes color yellow (NEGATIVE) to red (POSITIVE).
For FU of eradication, UBT is indicated at an interval of &gt;4w to avoid false negative results.
Sensitivity & specificity of Ig testing is similar to that of UBT. Because Hp. strains differ among areas, knowledge of local strains would optimise accuracy. Is of limited used in determining the success of Rx.
Stool Agtesting can be used for follow up of eradication, an interval of 8 weeks should be allowed. One prospective, multicenter study showed a positive result perform 7 days after completion of theraoy identified patients in whom eradication has been unsuccessful.
Stool Agtesting may be of particular use in children under 6 years
What does test result mean? Positive stool Ag, UBT, or biopsy indicates AP is likely c/by PUD due to HP
Positive Hp Ig may indicate a current/past inf. UBT may still be needed to confirm the inf. is a current one. A negative result: Hp unlikely. But, if SS persist, get a biopsy
What else to know?
UBT is not typically recommended for young children. The preferred test would be stool Ag test. AP has many reasons; an ulcer c/by Hp is only 1 of them. Use of antacids within 1w prior to testing, UBT may be falsely negative. ABT, PPI, bismuth may interfere with all but Ig test
Triple therapy regimens have a cure rate of 80%, without major SE, minimal ABR
Combination of two or more AB increases cure and reduces ABR. Many factors may result in Rx failure: microbial factors, compliance, geographical differences
Rx Strongly recommended
DU/GU; MALT lymphoma; Atrophic gastritis; Recent resection of gastric Ca
Treatment advised
Functional dyspepsia
Gastro-oesophageal reflux disease (patients requiring long-term acid suppressive therapy)
Use of NSAIDs
Culture : no more sensitive than skilled histology; used for ABR
Hp seen on GS: appear enlarged with abnormal morphology. Thickening of the CW of Hp occurs in previously given triple therapy. These abnormal bacteria were also present in patients who had follow up negative UBT